Xia M - Search Results

1

The Role of PARP Inhibitors in the Treatment of Prostate Cancer: Recent Advances in Clinical Trials.

Xia M, Guo Z, Hu Z. Xia M, et al. Biomolecules. 2021 May 12;11(5):722. doi: 10.3390/biom11050722. Biomolecules. 2021. PMID: 34066020 Free PMC article. Review.

2

Targeting the DNA damage response enhances CD70 CAR-T cell therapy for renal carcinoma by activating the cGAS-STING pathway.

Ji F, Zhang F, Zhang M, Long K, Xia M, Lu F, Li E, Chen J, Li J, Chen Z, Jing L, Jia S, Yang R, Hu Z, Guo Z. Ji F, et al. Among authors: xia m. J Hematol Oncol. 2021 Sep 23;14(1):152. doi: 10.1186/s13045-021-01168-1. J Hematol Oncol. 2021. PMID: 34556152 Free PMC article.

3

METTL3 promotes homologous recombination repair and modulates chemotherapeutic response in breast cancer by regulating the EGF/RAD51 axis.

Li E, Xia M, Du Y, Long K, Ji F, Pan F, He L, Hu Z, Guo Z. Li E, et al. Among authors: xia m. Elife. 2022 May 3;11:e75231. doi: 10.7554/eLife.75231. Elife. 2022. PMID: 35502895 Free PMC article.

4

METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma.

Li M, Xia M, Zhang Z, Tan Y, Li E, Guo Z, Fang M, Zhu Y, Hu Z. Li M, et al. Among authors: xia m. Int J Oncol. 2022 Sep;61(3):106. doi: 10.3892/ijo.2022.5396. Epub 2022 Jul 20. Int J Oncol. 2022. PMID: 35856434 Free PMC article.

5

Inhibition of O-GlcNAc transferase sensitizes prostate cancer cells to docetaxel.

Xia M, Wang S, Qi Y, Long K, Li E, He L, Pan F, Guo Z, Hu Z. Xia M, et al. Front Oncol. 2022 Nov 10;12:993243. doi: 10.3389/fonc.2022.993243. eCollection 2022. Front Oncol. 2022. PMID: 36439421 Free PMC article.

6

Analysis of N ⁶ -methyladenosine RNA Modification Levels by Dot Blotting.

Du Y, Xia M, Hu Z. Du Y, et al. Among authors: xia m. Bio Protoc. 2022 Dec 5;12(23):e4565. doi: 10.21769/BioProtoc.4565. eCollection 2022 Dec 5. Bio Protoc. 2022. PMID: 36561121 Free PMC article.

7

Rabies virus glycoprotein 29 (RVG29) promotes CAR-T immunotherapy for glioma.

Ji F, Xu L, Long K, Zhang F, Zhang M, Lu X, Xia M, Chen J, Du Y, Tang Y, Wu H, Shi Y, Ma R, Li J, Chen Z, Xu B, Zhang Q, Liang J, Jia S, Hu Z, Guo Z. Ji F, et al. Among authors: xia m. Transl Res. 2023 Sep;259:1-12. doi: 10.1016/j.trsl.2023.03.003. Epub 2023 Mar 26. Transl Res. 2023. PMID: 36977441

8

[Corrigendum] METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma.

Li M, Xia M, Zhang Z, Tan Y, Li E, Guo Z, Fang M, Zhu Y, Hu Z. Li M, et al. Among authors: xia m. Int J Oncol. 2023 Sep;63(3):101. doi: 10.3892/ijo.2023.5549. Epub 2023 Jul 28. Int J Oncol. 2023. PMID: 37503727 Free PMC article.

9

Corrigendum: Inhibition of O-GlcNAc transferase sensitizes prostate cancer cells to docetaxel.

Xia M, Wang S, Qi Y, Long K, Li E, He L, Pan F, Guo Z, Hu Z. Xia M, et al. Front Oncol. 2023 Jul 31;13:1257404. doi: 10.3389/fonc.2023.1257404. eCollection 2023. Front Oncol. 2023. PMID: 37588092 Free PMC article.

10

Genetic Variants of GBP4: Reduced Risks for Drug-Induced Acute Liver Failure in Non-Finnish European Population.

Liao TJ, Xia M, Hayashi P, Pan B, Aithal GP, Lucena MI, Andrade RJ, Rule JA, Lee WM, Rakela J, Huang R, Chen M. Liao TJ, et al. Among authors: xia m. Liver Int. 2025 Feb;45(2):e70011. doi: 10.1111/liv.70011. Liver Int. 2025. PMID: 39868816

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,685 results

Search Page

Filters